Corticosteroid-responsive cryptogenic chronic hepatitis: Evidence for seronegative autoimmune hepatitis

Digestive Diseases and Sciences

Volumn 52, Issue 9, 2007, Pages 2433-2437

  Gassert, Daniel J ^a   Garcia, Heriberto ^a   Tanaka, Katherine ^a   Reinus, John F ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Autoantibodies; Autoimmune hepatitis; Corticosteroid therapy; Cryptogenic chronic hepatitis; Seronegative autoimmune hepatitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRYPTOGENIC CHRONIC HEPATITIS; DATA BASE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTIBODIES, ANTINUCLEAR; BIOPSY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LIVER FAILURE; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34547839690     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9665-4     Document Type: Article

References (12)

1. Cook GC, Mulligan R, Sherlock S (1971) Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 158(40):159-185
2. Soloway RD, Summerskill WHJ, Baggenstoss AH, Geall MG, Gitnick GL, Elveback IR, Schoenfield LJ (1972) Clinical, biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63(5):820-833
3. Murray-Lyon IM, Stern RB, Williams R (1973) Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1(7806):735-737
4. Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF (1983) Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 85(3):713-717
5. Czaja AJ, Hay JE, Rakela J (1990) Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc 65:23-30
6. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA (1993) The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 104:1755-1761
7. Kaymakoglu S, Cakaloglu Y, Demir K, Turkoglu S, Badur S, Gurel S, Besisik F, Cevikbas U, Okten A (1998) Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? J Hepatol 28:78-83
8. Thiele DL, DuCharme L, Cunningham MR, Mimms LT, Cuthbert JA, Lee WM, Combes B (1996) Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Am J Gastroenterol 91(2):300-308
9. Manns M, Gerken G, Kyriatsoules A, Starlitz M, Meyer zum Buschenfelde KH (1987) Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against soluble liver antigen. Lancet 1:292-294
10. Alvarez F, Berg PA, Bianchi FB, et al. (1999) International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929-938
11. Krawitt EL (1996) Autoimmune hepatitis. N Engl J Med 334:897-903
12. Czaja AJ, Freese DK (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36(2):479-497